Skip to main content
. 2021 Jan;9(1):34. doi: 10.21037/atm-20-1471

Figure 4.

Figure 4

Combination treatment versus monotherapy in patients with LM. (A) PFS, OS and objective response; (B) the intrahepatic ORR and PFS. LM, liver metastasis; ORR, objective response rate; PFS, progression-free survival.